David Zigdon News Today

The MIGAL Galilee Research Institute, a mega-research center supported by Israel’s Ministry of Innovation, Science and Technology, announced the launch of the world’s first Agri-Photovoltaics Knowledge Center resource directory. Israeli workwear management company Polytex Technologies today announced the launch of its next-generation full cycle workwear solution, Polytex PRO and Israeli firms Granulate Partners and Vayyar […]

Conference led to launch of Israel APV Steering Committee, 110 pilot projects and joint ventures QIRYAT SHMONA, Israel, March 14, 2023 /PRNewswire/ -- As the world's leading proponent of

QIRYAT SHMONA, Israel, March 14, 2023 /PRNewswire/ -- As the world's leading proponent of agri-photovoltaics...

/PRNewswire/ -- As the worlds leading proponent of agri-photovoltaics (APV), the MIGAL Galilee Research Institute (MIGAL), a mega-research center supported by...

The Coalition for Epidemic Preparedness Innovations (CEPI) is granting $4.3 million to Israel’s MigVax to advance development of COVID-19 vaccines suitable for use in low- and middle-income countries.

The vaccines may protect against coronavirus variants, other coronaviruses and even 'Disease X' - but they are at a very early stage

Whether it’s in diagnostics, treatment or care management, Israel's innovators are busy inventing and adapting technologies to ease the coronavirus burden on the world.

by Karen Faulkner, Worthy News Correspondent (Worthy News) – Israeli scientists are developing an oral COVID-19 vaccine that may be ready as a booster shot for humans within nine months, the Times of Israel reports. The vaccine has so far worked well on rats, whose antibody levels increased with no side effects. Work on producing the oral vaccine began at the state-funded Migal Galilee Research Institute in northern Israel, and is now centered in the affiliated company MigVax, the Times of Is...

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. ...

An oral COVID-19 vaccine booster developed in Israel shows promising results in animal trials, and researchers expect to make it available within nine months.